ODDB.org: Open Drug Database

MSD Merck Sharp & Dohme AG - HBVAXPRO 10, Injektionssuspension

Swissmedic Registration	00663	Sequence	01
Product name	HBVAXPRO 10	Description	Injektionssuspension
ATC-Classification	J07BC01	ATC-Description	Hepatitis B, Purified Antigen
Introduction of Sequence	20.08.2002

Composition

hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxyphosphas sulfas amorphus, borax, natrii chloridum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 3.5 mg.

Packungsbestandteile

Galenic Form

Injection suspension

Excipiens

Active Agent	Dose
Hepatitidis b viri Antigenum Adnr	10 µg/ml

BAG: Active Agent	Dose
Vaccinum Hepatitidis b (Adnr) Hbsag	10 mcg

Inactive agents	Dose
Alumine	0.5 mg/ml
Borax
Sodium Chloride

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	Fertigspritze(n) à 1 ml	25.23	45.40	B	SL	Yes
011	Durchstechflasche(n) à 1 ml	PR	PR	B		Yes
012	10 1 Fertigspritze(n) à 1 ml	252.30	306.35	B	SL	Yes

2024	©ywesee GmbH